Livmoniplimab Antibody
Livmoniplimab (ABBV-151; ARGX-115) is a humanized monoclonal antibody that inhibits the LRRC32 (GARP) -mediated release of TGFβ1. It is a research tool for investigating TGFβ biology in oncology, with applications in both in vitro cellular assays and in vivo models of solid tumors.
Product Specifications
Product Name Alternative
ABBV151, ABBV-151, ARGX115, ARGX-115, MHG8, MHG-8
Target
TGF-beta/Smad
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Stem Cell & Developmental Biology
Concentration
37.374 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
~150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC550525-100 1x 100 µL
CD63 (MX-49.129.5), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC551037-100 1x 100 µL
CD44 Standard (DF1485), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740806-100 1x 100 µL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details